Philippines vs South Africa: Young people (ages 15-24) newly infected with HIV
Philippines
14,000
in 2024
South Africa
71,000
in 2024
Philippines rank
4th
South Africa rank
1st
Young people (ages 15-24) newly infected with HIV over time
- Philippines
- South Africa
How they compare
South Africa currently reports 71,000 against 14,000 in Philippines, a difference of 57,000.
That makes South Africa's figure about 5.1 times Philippines's.
Across all 35 years both countries report, South Africa has been ahead every year.
Philippines ranks 4th and South Africa ranks 1st of 137 countries.
South Africa has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Philippines | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 110 | 158,000 | 157,890 | South Africa |
| 2000s | 816 | 191,000 | 190,184 | South Africa |
| 2010s | 4,900 | 118,900 | 114,000 | South Africa |
| 2020s | 11,300 | 74,800 | 63,500 | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher young people (ages 15-24) newly infected with hiv, Philippines or South Africa?
- South Africa, at 71,000 against 14,000 in Philippines as of 2024.
- What is the difference in young people (ages 15-24) newly infected with hiv between Philippines and South Africa?
- 57,000, with South Africa ahead.
- How many years of comparable data are there for Philippines and South Africa?
- 35 years are reported by both, from 1990 to 2024.
- How do Philippines and South Africa rank globally for young people (ages 15-24) newly infected with hiv?
- Philippines ranks 4th and South Africa ranks 1st of 137 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Young people (ages 15-24) newly infected with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of young people (ages 15-24) newly infected with HIV.